Tender for Iodine Products (I-123)

Amgros I/S is conducting a tender for iodine products within the area of Radioactive Medicinal Products for the five regions in Denmark. This procurement process aims to secure the supply of essential radioactive medicinal products, specifically focusing on Iodine-123 (I-123), which is a crucial radioisotope used in diagnostic imaging, particularly in nuclear medicine for thyroid scans and other diagnostic procedures. The tender is structured into one to three sub-agreements, the specifics of which are detailed in the "Tilbudslisten" (List of Offers/Tender List). This indicates a potential for different suppliers to cover distinct aspects or quantities of the required iodine products, allowing for flexibility and specialization within the supply chain. The scope of the tender covers the needs of all five Danish regions, highlighting the centralized procurement approach managed by Amgros I/S for these specialized pharmaceutical products. Interested parties are expected to review the detailed specifications provided in the tender documentation to understand the precise requirements, delivery schedules, quality standards, and contractual obligations associated with each potential sub-agreement. This initiative underscores the commitment to ensuring a stable and efficient supply of critical radioactive medicinal products for healthcare services across Denmark.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums, with an estimated budget of DKK 20.0 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.